Article
Identification of novel Nrf2/Keap1 pathway mutations in pediatric acute lymphoblastic leukemia.
Pediatric hematology and oncology - 1 Feb 2020
Akın-Balı Dilara Fatma, Aktas Sedef Hande, Unal Mehmet Altay, Kankılıc Teoman
Abstract excerpt
Acute lymphoblastic leukemia (ALL) is a malignancy of lymphoid progenitor cells, characterized by a wide range of biological and clinical heterogeneity. Oxidative stress is a common problem observed in carcinogenesis and it is involved in developing treatment resistance. Nuclear Factor Erythroid-2-Like 2 (Nrf2) transcription factor is the main regulator of antioxidant responses. The levels of reactive oxygen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
